Loading...
Carmat SA
ALCAR.PA•EURONEXT
HealthcareMedical - Devices
$0.80
$0.01(1.41%)
Carmat SA (ALCAR.PA) Stock Overview
Explore Carmat SA’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for ALCAR.PAStats details for ALCAR.PA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for ALCAR.PAAnalyst Recommendations details for ALCAR.PA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. It The company was founded in 2008 and is headquartered in Vélizy-Villacoublay, France.
CEO
Mr. Stephane Piat
Employees
162
Headquarters
36, avenue de l'Europe, Vélizy-Villacoublay
Founded
2010